Literature DB >> 15520039

Acceptability and feasibility of a community-based screening programme for melanoma in Australia.

John B Lowe1, Jacqueline Ball, Brigid M Lynch, Louise Baldwin, Monika Janda, Warren R Stanton, Joanne F Aitken.   

Abstract

The evaluation of a community-based screening programme for melanoma (SkinWatch) in 18 regional communities (total adult population >30 years 63 035) in Queensland, Australia is described. The aim of the SkinWatch programme was to promote whole-body skin screening for melanoma by primary care physicians. The programme included community education, education and support for local medical practitioners and open-access skin screening clinics. Programme delivery was achieved through assistance of local volunteers. All programme activities and resources were recorded for process evaluation. A baseline telephone survey (n = 3110) and a telephone survey four months after programme launch (n = 680) assessed community awareness of the SkinWatch programme and, 37 face-to-face interviews with community members, doctors and community leaders were conducted to assess satisfaction with the programme. A sample of 1043 of 16,383 residents who attended the skin screening clinics provided as part of the programme were interviewed to assess reasons for attending, and positive and negative aspects of SkinWatch programme. Community awareness of the SkinWatch programme increased by over 30% (p < 0.001) within four months of the start of the programme. Interview participants described the SkinWatch programme as a useful service for the communities and 90% stated they would revisit the clinics. A total of 43% of all attendees were over 50 years old, and nearly 50% were men. These findings demonstrate the acceptability and feasibility of a community-based screening programme for melanoma in rural areas. Volunteers were instrumental in increasing community ownership of and involvement in the SkinWatch programme.

Entities:  

Mesh:

Year:  2004        PMID: 15520039     DOI: 10.1093/heapro/dah405

Source DB:  PubMed          Journal:  Health Promot Int        ISSN: 0957-4824            Impact factor:   2.483


  6 in total

1.  Screening for reducing morbidity and mortality in malignant melanoma.

Authors:  Minna Johansson; John Brodersen; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2019-06-03

2.  Conflicts and contradictions in current skin cancer screening guidelines.

Authors:  K Y Wojcik; L A Escobedo; K A Miller; M Hawkins; O Ahadiat; S Higgins; A Wysong; Myles Cockburn
Journal:  Curr Dermatol Rep       Date:  2017-11-04

3.  Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma.

Authors:  J Hübner; A Waldmann; A C Geller; M A Weinstock; N Eisemann; M Noftz; S Bertram; S Nolte; B Volkmer; R Greinert; E Breitbart; A Katalinic
Journal:  Br J Cancer       Date:  2016-11-29       Impact factor: 7.640

4.  A qualitative descriptive study of a novel nurse-led skin cancer screening model in rural Australia.

Authors:  Kristen Glenister; Sophie Witherspoon; Alan Crouch
Journal:  BMC Health Serv Res       Date:  2022-08-10       Impact factor: 2.908

Review 5.  Overdiagnosis and overtreatment of early detected prostate cancer.

Authors:  C H Bangma; S Roemeling; F H Schröder
Journal:  World J Urol       Date:  2007-02-14       Impact factor: 4.226

Review 6.  Educational Interventions to Support Primary Care Provider Performance of Diagnostic Skin Cancer Examinations: A Systematic Literature Review.

Authors:  Eliza L Posada; Kyle C Lauck; Tiffaney Tran; Kate J Krause; Kelly C Nelson
Journal:  J Cancer Educ       Date:  2022-01-18       Impact factor: 2.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.